1. Home
  2. All topics: A to Z
  3. Coronavirus
  4. Threats and outbreaks
  5. COVID-19
  6. Latest evidence

Latest evidence on COVID-19

Coronaviruses

General background of SARS-CoV-2, virus evolution and seasonality.

Risk factors and risk groups

Risk factors,risk groups and demographic profiles.

Transmission

Viral shedding, virus and substances of human origin (SoHO), role of asymptomatic and pre-symptomatic individuals and transmission risks in different settings

Infection

Incubation period, pathology and pathogenesis, viral shedding, and co-infections and secondary infections.

Clinical characteristics

Symptoms and signs, severity, complications of COVID-19 infection.

Diagnostic testing and screening

Diagnostic specimens, assay types, in-house tests versus in vitro diagnostic medical devices, intended use, rapidity and point of testing, diagnostic accuracy and validation, biosafety, testing capacity and methodologies

Immune responses and immunity

Immune responses (cell-mediated immune response and antibody-mediated immune response and protective immunity) and population immunity

Vaccines and treatment

Vaccines and pharmaceutical prophylaxis and treatment

Read more

Page last updated 11 Jun 2020

Latest risk assessment

Publication

Risk assessment: SARS-CoV-2 - increased circulation of variants of concern and vaccine rollout in the EU/EEA, 14th update

Risk assessment -

This risk assessment provides an overall update on the COVID-19 situation in the EU/EEA, including latest data on the situation with SARS-CoV-2 variants of concern covered by previous targeted risk assessments.

Risk assessment: SARS-CoV-2 - increased circulation of variants of concern and vaccine rollout in the EU/EEA, 14th update - EN - [PDF-1.44 MB]

Read more